EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition‐Based Deep Learning

Yingjing Zhang, Tong Tong, Bowen Hou, Tian Yu, Pengfei Su, Jianchun Yu, Yakai Huang iD

Cancer Medicine · 2026-05 · 15 (5)

DOI: 10.1002/cam4.71886 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 01.05.2026. Verfasst von Yingjing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Deep Learning, Stomach Neoplasms, Neoadjuvant Therapy, Body Composition. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study sought to develop an innovative body composition (BC)‐based deep learning (DL) model to precisely evaluate survival in gastric cancer (GC) patients undergoing neoadjuvant treatment (NT). Materials and Methods This retrospective study included GC patients undergoing NT from two centers. CT images both pre‐NT and post‐NT were preprocessed, focusing on the automatic segmentation of subcutaneous fat, visceral fat, and skeletal muscle regions using TotalSegmentator. Delta Radiomics features were extracted using Pyradiomics. After feature fusion and selection, the optimal model is Naive Bayes (Rad model). A hybrid DL model was developed by combining ResNet18 and Transformer networks for feature extraction. The Clinic_Rad_DL model was constructed by combining clinical features, radiomic signatures, and DL signatures. The ExtraTree classifier was used for the Clinic_Rad_DL model, while a separate Cox regression model was developed for survival analysis using the same features.

Results

A total of 356 patients (mean age, 59 ± 10 years; 264 males [74.2%]) were enrolled and divided into training, validation, and test sets in a 7:2:1 ratio. The DL model outperformed the Rad model. The Clinic_Rad_DL model outperformed both Rad model and DL model, with AUC of 0.915, 0.890, and 0.890 in training, validation, and test sets, respectively. The Cox proportional hazards model showed C‐index of 0.806, 0.803, and 0.819, effectively stratifying patients into high‐ and low‐risk groups with significant survival differences.

Conclusion

The study developed and validated a BC‐based DL model to predict survival in GC patients undergoing NT, offering potential for personalized treatment strategies in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningStomach NeoplasmsNeoadjuvant TherapyBody CompositionHumansMalePrognosisFemaleRetrospective StudiesMiddle AgedRadiomicsTomography, X-Ray ComputedAged

Stichwörter der Autor:innen

body compositiondeep learninggastric cancerneoadjuvant treatmentradiomic

Autor:innen und Institutionen

  • Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
  • Department of Gastrointestinal Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Department of General Surgery, Cancer Center, Division of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Zhejiang, Hangzhou, China.

ORCID-Profile: Yakai Huang

Förderung

  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Zhang, Y., Tong, T., Hou, B., Yu, T., Su, P., Yu, J., & Huang, Y. (2026). Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition‐Based Deep Learning. Cancer Medicine, 15(5). https://doi.org/10.1002/cam4.71886

Vancouver

Zhang Y, Tong T, Hou B, Yu T, Su P, Yu J, et al. Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition‐Based Deep Learning. Cancer Medicine. 2026;15(5). doi:10.1002/cam4.71886

BibTeX
@article{Zhang2026,
  author = {Zhang, Yingjing and Tong, Tong and Hou, Bowen and Yu, Tian and Su, Pengfei and Yu, Jianchun and Huang, Yakai},
  title = {Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition‐Based Deep Learning},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/cam4.71886}
}
Kostenlos starten →